UTE-28086-46255
2 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 797 / TX
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-28
Registered in v-safe
-
2021-02-28
Dose 1 — Pfizer-BioNTech
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-19
- 2021-03-21
- 2021-03-28
-
2021-03-30
Dose 2 — Pfizer-BioNTech
- 2021-04-04
- 2021-04-05
- 2021-07-01
-
2021-09-29
Survey response — 6 months, dose 2MedDRA: Chills, Headache, Insomnia, Nausea, Oropharyngeal pain, Pain, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Chills, body aches, fever, headaches, nausea, sore throat, insomnia,MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-28 | Pfizer-BioNTech | |
| 2 | 2021-03-30 | Pfizer-BioNTech |
Free text
Release 9 — 6 months, dose 2
Symptoms: Chills, body aches, fever, headaches, nausea, sore throat, insomnia,
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release